Comprehensive Analysis of the Value of Dynamic Changes in Circulating Tumor DNA in Small Cell Lung Cancer

循环肿瘤DNA 医学 化疗 肿瘤科 内科学 价值(数学) 危险分层 肺癌 残余物 循环肿瘤细胞 微小残留病 癌症研究 DNA 肺 预测值 癌症 临床试验 剩余风险 生物 产量(工程) 化疗方案 细胞 完全响应 免疫学 细胞毒性
作者
Abhishek Ajay,Reza Ferdousi,Peronne L. Joseph,Seren Durer,Ali Rezvani,Zhengyi Chen,Gary M. Wildey,Minh Lam,Pingfu Fu,Afshin Dowlati
出处
期刊:JCO precision oncology [Lippincott Williams & Wilkins]
卷期号:9 (9): e2500574-e2500574 被引量:5
标识
DOI:10.1200/po-25-00574
摘要

PURPOSE Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy associated with an exceptionally poor prognosis. A limitation in its standard-of-care management is the absence of practical molecular tools for monitoring disease progression. Circulating tumor DNA (ctDNA) has emerged as a promising biomarker with potential applications in prognostication, early detection of cancer recurrence, refined evaluation of treatment response, and improved disease surveillance. MATERIALS AND METHODS We analyzed serial plasma samples from 81 patients with SCLC using a 105-gene hybrid capture-based next-generation sequencing liquid biopsy assay at three key time points: diagnosis, postchemotherapy, and clinical relapse. RESULTS Extensive-stage (ES) patients demonstrated significantly higher median baseline maximum variant allele frequency (VAF max ) compared with limited-stage cases. Notably, limited-stage patients with VAF max >40% experienced outcomes similar to those with ES disease. Across the cohort, median VAF max values declined from 53.30% at baseline to 0.15% during remission and then rose to 38.65% at relapse, reflecting initial therapeutic sensitivity followed by disease recurrence that remained unremitting. Baseline VAF max correlated with the overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). Moreover, disease-free survival (DFS), defined as the time to relapse from the date of clinical response (evaluated post–4-cycle chemotherapy), was significantly associated with baseline VAF max and a decline in VAF max of <99.89% at remission. Relapse genomic profiles largely mirrored baseline alterations, although some patients showed novel mutations. CONCLUSION Median ctDNA VAF max was strongly associated with OS, PFS, DFS, and ORR. Importantly, patients with detectable residual alterations at completion of prescribed chemotherapy exhibited a markedly shorter DFS, less than that of patients with lower detectable residual alterations, highlighting the potential utility of ctDNA in risk stratification and the value of early trial enrollment for high-risk subgroups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
LUCKY发布了新的文献求助10
刚刚
111111发布了新的文献求助10
1秒前
1秒前
酷炫笑柳发布了新的文献求助10
1秒前
1秒前
1秒前
2秒前
JamesPei的应助被阿爸嘚嘚嘚采纳,获得10
2秒前
2秒前
2秒前
雪山大地发布了新的文献求助20
2秒前
eas发布了新的文献求助10
3秒前
3秒前
清风完成签到,获得积分10
4秒前
傲娇钢笔完成签到 ,获得积分10
4秒前
舒心的瑛完成签到,获得积分10
4秒前
迅速完成签到,获得积分20
4秒前
饼的书发布了新的文献求助10
5秒前
5秒前
XCL发布了新的文献求助10
5秒前
霸气的如冬完成签到,获得积分10
5秒前
ahxyk完成签到,获得积分10
5秒前
hhud发布了新的文献求助10
5秒前
冉苗苗完成签到 ,获得积分10
5秒前
乐乐的应助被伯赏夜南采纳,获得10
6秒前
弦弦弦完成签到,获得积分10
6秒前
6秒前
6秒前
赘婿的应助被学术饕餮采纳,获得10
7秒前
Hu发布了新的文献求助10
7秒前
Owen的应助被samo采纳,获得10
8秒前
爆米花的应助被Ringo采纳,获得40
8秒前
8秒前
jiabangou发布了新的文献求助10
8秒前
Owen的应助被学术爬虫采纳,获得10
8秒前
wanci的应助被筱南竹折采纳,获得10
9秒前
9秒前
我要吃饭发布了新的文献求助10
10秒前
迅速发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163835
求助须知:如何正确求助?哪些是违规求助? 9557925
关于积分的说明 21742693
捐赠科研通 7754454
什么是DOI,文献DOI怎么找? 3428350
关于科研通互助平台的介绍 2553034
邀请新用户注册赠送积分活动 2472982